Cargando…
SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
Autores principales: | Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629452/ https://www.ncbi.nlm.nih.gov/pubmed/34452540 http://dx.doi.org/10.31557/APJCP.2021.22.8.2311 |
Ejemplares similares
-
Anti-SARS-CoV-2 spike IgG antibodies prevalence: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023) -
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020) -
Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020) -
Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection
por: Orth-Höller, Dorothea, et al.
Publicado: (2021) -
Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)